Attend a full virtual consult with a boardcertified obesity medicine clinician to create your plan
Tesofensine and semaglutide solve different problems, so better depends on what is actually limiting progress
How slow is too slow though
The Shelf Life Extension Program, originally developed for the Department of Defense, tested over 3,000 lots representing 122 drug products and found that 88% of conventional medications retained potency well beyond their labeled dates, sometimes by 66 months on average
Why the mechanism should guide the choice For someone with severe obesity or stacked cardiometabolic risk , tirzepatides dualsignal intensity can be an advantage if they are ready for tighter titration, closer followup, and stricter nutrition to protect lean mass and minimize GI symptoms. For someone aiming for strong but steady weight loss with a focus on tolerability and habitbuilding , semaglutides singlepathway action can be the better match, giving real movement in weight and A1c without feeling like the appetite dial is turned all the way down